From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function
暂无分享,去创建一个
W. Gronwald | P. Oefner | A. Köttgen | K. Suhre | G. Kastenmüller | R. Mohney | K. Eckardt | K. Dettmer | P. Sekula | Lisa Ellmann | Franziska C. Vogl
[1] Uwe Christians,et al. Amino acids in a targeted versus a non-targeted metabolomics LC-MS/MS assay. Are the results consistent? , 2016, Clinical biochemistry.
[2] J. Roy,et al. Supplementary Material for: Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study , 2016 .
[3] Harold I. Feldman,et al. Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study , 2016, American Journal of Nephrology.
[4] T. Spector,et al. Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms , 2016, PloS one.
[5] Christian Gieger,et al. A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. , 2016, Journal of the American Society of Nephrology : JASN.
[6] E. Ferrannini,et al. Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. , 2016, The Journal of clinical endocrinology and metabolism.
[7] Christian Gieger,et al. Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality , 2015, PLoS genetics.
[8] Florian Kronenberg,et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] Thomas Kocher,et al. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.
[10] T. Meyer,et al. Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.
[11] Christian Gieger,et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] R. Vasan,et al. A combined epidemiologic and metabolomic approach improves CKD prediction. , 2013, Journal of the American Society of Nephrology : JASN.
[13] Kai-Uwe Eckardt,et al. Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.
[14] K. Suhre,et al. Metabolomics platforms for genome wide association studies--linking the genome to the metabolome. , 2013, Current opinion in biotechnology.
[15] C. Gieger,et al. Serum metabolite concentrations and decreased GFR in the general population. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] Harold I Feldman,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.
[17] Rupasri Mandal,et al. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update , 2012, Genome Medicine.
[18] Hans-Ulrich Prokosch,et al. The German Chronic Kidney Disease (GCKD) study: design and methods. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] B. McManus,et al. The Human Serum Metabolome , 2011, PloS one.
[20] Christian Gieger,et al. Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.
[21] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[22] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[23] H. Senn,et al. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.
[24] A. Hishida,et al. The diagnostic value of serum concentrations of 2-(α-mannopyranosyl)-L-tryptophan for normal renal function , 2004 .
[25] A. Hishida,et al. Tryptophan glycoconjugate as a novel marker of renal function. , 2001, The American journal of medicine.
[26] M. Herderich,et al. Tryptophan glycoconjugates in food and human urine. , 1999, The Biochemical journal.
[27] W. H. Hannon,et al. Pseudouridine is unsuitable as an endogenous renal clearance marker. , 1988, Clinical chemistry.
[28] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[29] T. Russo,et al. Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography. , 1983, Analytical biochemistry.
[30] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[31] Hans-Ulrich Prokosch,et al. Designing and implementing a biobanking IT framework for multiple research scenarios. , 2012, Studies in health technology and informatics.
[32] M. Marcelli,et al. Design and Methods , 2011 .
[33] V. Spustová,et al. Pseudouridine excretion in healthy subjects and its accumulation in renal failure. , 1992, Nephron.